CanSino Biologics Inc. (688185.SS)

CNY 63.42

(0.21%)

Revenue Summary of CanSino Biologics Inc.

  • CanSino Biologics Inc.'s latest annual revenue in 2023 was 345.18 Million CNY , down -66.14% from previous year.
  • CanSino Biologics Inc.'s latest quarterly revenue in 2024 Q3 was 261.05 Million CNY , up 39.71% from previous quarter.
  • CanSino Biologics Inc. reported a annual revenue of 1.03 Billion CNY in annual revenue 2022, down -76.02% from previous year.
  • CanSino Biologics Inc. reported a annual revenue of 4.29 Billion CNY in annual revenue 2021, up 23086.49% from previous year.
  • CanSino Biologics Inc. reported a quarterly revenue of 186.85 Million CNY for 2024 Q2, up 66.37% from previous quarter.
  • CanSino Biologics Inc. reported a quarterly revenue of 261.05 Million CNY for 2024 Q3, up 39.71% from previous quarter.

Annual Revenue Chart of CanSino Biologics Inc. (2023 - 2016)

Historical Annual Revenue of CanSino Biologics Inc. (2023 - 2016)

Year Revenue Revenue Growth
2023 345.18 Million CNY -66.14%
2022 1.03 Billion CNY -76.02%
2021 4.29 Billion CNY 23086.49%
2020 18.54 Million CNY 712.13%
2019 2.28 Million CNY 101.71%
2018 1.13 Million CNY 287.94%
2017 -602.32 Thousand CNY -107.35%
2016 8.19 Million CNY 0.0%

Peer Revenue Comparison of CanSino Biologics Inc.

Name Revenue Revenue Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 9.65 Billion CNY 96.425%
Yabao Pharmaceutical Group Co., Ltd 2.9 Billion CNY 88.137%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 75.51 Billion CNY 99.543%
Harbin Pharmaceutical Group Co., Ltd. 15.33 Billion CNY 97.75%
Tasly Pharmaceutical Group Co., Ltd 8.54 Billion CNY 95.961%
Zhejiang Medicine Co., Ltd. 7.79 Billion CNY 95.571%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 8.22 Billion CNY 95.802%
Lionco Pharmaceutical Group Co.,Ltd. 196.83 Million CNY -75.369%
Humanwell Healthcare (Group) Co.,Ltd. 24.33 Billion CNY 98.581%
Ginwa Enterprise (Group) Inc. 565.4 Million CNY 38.949%
Joincare Pharmaceutical Group Industry Co.,Ltd. 16.64 Billion CNY 97.926%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 644.97 Million CNY 46.481%
China Animal Husbandry Industry Co., Ltd. 5.4 Billion CNY 93.615%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 860.93 Million CNY 59.906%
Zhejiang Huahai Pharmaceutical Co., Ltd. 8.21 Billion CNY 95.797%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.87 Billion CNY 81.564%
Ningbo Menovo Pharmaceutical Co., Ltd. 1.21 Billion CNY 71.625%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 5.52 Billion CNY 93.751%
Chongqing Taiji Industry(Group) Co.,Ltd 15.43 Billion CNY 97.763%
HPGC Renmintongtai Pharmaceutical Corporation 10.38 Billion CNY 96.678%
Nanjing Well Pharmaceutical Group Co.,Ltd. 1.15 Billion CNY 70.136%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 3.73 Billion CNY 90.756%
Henan Lingrui Pharmaceutical Co., Ltd. 3.31 Billion CNY 89.576%
Shenzhen Chipscreen Biosciences Co., Ltd. 515.78 Million CNY 33.076%
Guizhou Yibai Pharmaceutical Co., Ltd. 2.77 Billion CNY 87.574%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 4.86 Billion CNY 92.909%
Zhongzhu Healthcare Holding Co.,Ltd 580.05 Million CNY 40.492%
Beijing Tongrentang Co., Ltd 17.86 Billion CNY 98.067%
KPC Pharmaceuticals, Inc. 7.62 Billion CNY 95.475%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 845.34 Million CNY 59.167%
North China Pharmaceutical Company Ltd. 10.12 Billion CNY 96.589%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 10.22 Billion CNY 96.623%
Tibet Weixinkang Medicine Co., Ltd. 1.32 Billion CNY 73.902%
China National Medicines Corporation Ltd. 49.69 Billion CNY 99.305%
Zhejiang Hisun Pharmaceutical Co., Ltd. 10.37 Billion CNY 96.672%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 3.13 Billion CNY 89.001%
ChengDu ShengNuo Biotec Co.,Ltd. 430.98 Million CNY 19.909%
Dali Pharmaceuticalco.,Ltd 87.26 Million CNY -295.534%
Changchun BCHT Biotechnology Co. 1.81 Billion CNY 80.947%
Zhejiang Shengda Bio-Pharm Co., Ltd. 727.4 Million CNY 52.546%
Shanghai Jiaoda Onlly Co.,Ltd 291.91 Million CNY -18.246%
Jiang Zhong Pharmaceutical Co.,Ltd 4.32 Billion CNY 92.023%
Mayinglong Pharmaceutical Group Co., LTD. 3.13 Billion CNY 88.996%
Cisen Pharmaceutical Co., Ltd. 4.46 Billion CNY 92.265%
Hunan Warrant Pharmaceutical Co.,Ltd 1.43 Billion CNY 75.908%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 41.39 Billion CNY 99.166%
Jianmin Pharmaceutical Group Co.,Ltd. 4.18 Billion CNY 91.75%
Hunan Fangsheng Pharmaceutical Co., Ltd. 1.62 Billion CNY 78.804%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 3.09 Billion CNY 88.853%
Guobang Pharma Ltd. 5.34 Billion CNY 93.547%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 672.96 Million CNY 48.707%
Kangmei Pharmaceutical Co., Ltd. 4.87 Billion CNY 92.918%
Shandong Buchang Pharmaceuticals Co., Ltd. 13.24 Billion CNY 97.394%
Zhejiang Starry Pharmaceutical Co.,Ltd. 2.17 Billion CNY 84.148%
Henan Taloph Pharmaceutical Stock Co.,Ltd 2.06 Billion CNY 83.324%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 3.79 Billion CNY 90.913%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 3.93 Billion CNY 91.22%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 932.12 Million CNY 62.968%
Shanghai Shyndec Pharmaceutical Co., Ltd. 11.93 Billion CNY 97.107%
Shanghai Yizhong Pharmaceutical Co., Ltd. 360.25 Million CNY 4.184%
Tibet Rhodiola Pharmaceutical Holding Co. 3.09 Billion CNY 88.851%
Sichuan Huiyu Pharmaceutical Co., Ltd. 920.34 Million CNY 62.494%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 671.62 Million CNY 48.605%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 2.17 Billion CNY 84.123%
Shandong Lukang Pharmaceutical Co.,Ltd. 6.14 Billion CNY 94.384%